Clinical Trial Update: A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and effects of IRX-2 in operable head and neck cancer completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• IRX-2

Snippet

Sponsor: Brooklyn ImmunoTherapeutics, LLC | Conditions: Squamous Cell Carcinoma of the Head and Neck | Phase 2 | Status: COMPLETED | Results posted: 2012-02-08